Mayo-backed Resoundant gains traction with tool to diagnose liver disease
As liver diseases grow, the noninvasive scan provides an alternative to a biopsy.
Diseases of the liver don’t tend to generate the same kinds of urgent public discussion as other deadly, progressive conditions like breast cancer, AIDS or diabetes.
But liver cancer and liver cirrhosis together kill more people worldwide each year (2 million plus) than those conditions. And the incidence is growing — especially the condition known as nonalcoholic fatty liver disease, which tends to crop up in people with obesity or diabetes and can lead to cirrhosis and cancer.
Read the full story at: http://www.startribune.com/mayo-backed-resoundant-gains-traction-with-tool-to-diagnose-liver-disease/492205141/